Healthcare
Aardvark Therapeutics, Inc.
AARD$6.10+5.35%
Price is delayed.
Add to Watchlist
About Aardvark Therapeutics, Inc.
Aardvark Therapeutics is a drug development company working on treatments for metabolic diseases like diabetes and obesity. The company is still in the early stages of testing, with no approved medicines on the market yet. They focus on small-molecule drugs, which are chemical compounds small enough to be taken as pills. The company was founded in 2017 and is based in San Diego.
Loading chart...
Members only
Full research is for ConvictionStocks members
Members read the rest of this page. Where we have it for this company, that is:
- What each number means, in plain English, with the Wall Street name where the two differ.
- A plain-English summary of the company.
- How many analysts cover it, and the count behind each rating.
- Recent news, dated.
Get the free weekly market digest
The week's biggest movers, every Sunday. No spam.
Look up another company
Related Research
More Healthcare stocks to explore